FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joseph Franciosa

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Geographic Areas

United States

Living Beings

African Americans

Procedures

Co-author Network

Publications

TOP 3
Clyde W Yancy; Jalal K Ghali; Virginia M Braman; Michael L Sabolinski; Manuel Worcel; W Tad Archambault; Joseph A Franciosa
Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
Michael B Fowler; Sandra R Lottes; Jeanenne J Nelson; Mary Ann Lukas; Edward M Gilbert; Barry Greenberg; Barrie Massie; William T Abraham; Joseph A Franciosa
Beta-blocker dosing in community-based treatment of heart failure.
Barrie Massie; Jeanenne J Nelson; Mary Ann Lukas; Barry Greenberg; Michael B Fowler; Edward M Gilbert; William T Abraham; Sandra R Lottes; Joseph A Franciosa
Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Franciosa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Clyde W Yancy; Jalal K Ghali; Virginia M Braman; Michael L Sabolinski; Manuel Worcel; W Tad Archambault; Joseph A Franciosa
Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
The American journal of cardiology 2007;100(4):684-9.
2007: Michael B Fowler; Sandra R Lottes; Jeanenne J Nelson; Mary Ann Lukas; Edward M Gilbert; Barry Greenberg; Barrie Massie; William T Abraham; Joseph A Franciosa
Beta-blocker dosing in community-based treatment of heart failure.
American heart journal 2007;153(6):1029-36.
2007: Barrie Massie; Jeanenne J Nelson; Mary Ann Lukas; Barry Greenberg; Michael B Fowler; Edward M Gilbert; William T Abraham; Sandra R Lottes; Joseph A Franciosa
Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice.
The American journal of cardiology 2007;99(9):1263-8.
2007: William T Abraham; Barrie Massie; Mary Ann Lukas; Sandra R Lottes; Jeanenne J Nelson; Michael B Fowler; Barry Greenberg; Edward M Gilbert; Joseph A Franciosa
Tolerability, safety, and efficacy of beta-blockade in black patients with heart failure in the community setting: insights from a large prospective beta-blocker registry.
Congestive heart failure (Greenwich, Conn.) 2007;13(1):16-21.
2006: Barry Greenberg; Sandra R Lottes; Jeanenne J Nelson; Mary Ann Lukas; Michael B Fowler; Barrie Massie; William T Abraham; Edward M Gilbert; Joseph A Franciosa
Predictors of clinical outcomes in patients given carvedilol for heart failure.
The American journal of cardiology 2006;98(11):1480-4.
2006: Joseph A Franciosa; Jeanenne J Nelson; Mary Ann Lukas; Sandra R Lottes; Barrie Massie; Michael B Fowler; Barry Greenberg; Edward M Gilbert; William T Abraham
Heart failure in community practice: relationship to age and sex in a beta-blocker registry.
Congestive heart failure (Greenwich, Conn.) 2006;12(6):317-23.
2004: Joseph A Franciosa; Barrie Massie; Mary Ann Lukas; Jeanenne J Nelson; Sandra R Lottes; William T Abraham; Michael Fowler; Edward M Gilbert; Barry Greenberg
Beta-blocker therapy for heart failure outside the clinical trial setting: findings of a community-based registry.
American heart journal 2004;148(4):718-26.
2004: Joseph A Franciosa
The potential role of community-based registries to complement the limited applicability of clinical trial results to the community setting: heart failure as an example.
The American journal of managed care 2004;10(7 Pt 2):487-92.
2002: Anne L Taylor; Jay N Cohn; Manuel Worcel; Joseph A Franciosa
The African-American Heart Failure Trial: background, rationale and significance.
Journal of the National Medical Association 2002;94(9):762-9.
2002: Joseph A Franciosa; Anne L Taylor; Jay N Cohn; Clyde W Yancy; Susan Ziesche; Adeoye Y Olukotun; Elizabeth Ofili; Keith Ferdinand; Joseph Loscalzo; Manuel Worcel
African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology.
Journal of cardiac failure 2002;8(3):128-35.
2000: Joseph A Franciosa; William T Abraham; M Fowler; Edward M Gilbert; Barry Greenberg; Barrie Massie; T Chen; Mary Ann Lukas; Jeanenne J Nelson
Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE). COHERE Participant Physicians.
Journal of cardiac failure 2000;6(3):264-71.
1999: Joseph A Franciosa
Beta-adrenergic blocking agents: past, present, and future perspectives.
Coronary artery disease 1999;10(6):369-76.